|
- Lung Cancer - Medscape
Lung Cancer : Review in-depth clinical information, latest medical news, and guidelines on lung cancer, specifically small-cell lung cancer and non-small-cell lung cancer Read the latest
- Small Cell Lung Cancer in 2024: Treatment Advances - Medscape
This is Mark Kris, going over developments in small cell lung cancer in 2024 that have advanced therapy in the field I think the most dramatic one is the long overdue emergence of checkpoint
- Two Lung Cancer Drugs Recommended by EMA - Medscape
Amgen Drug Cuts Small Cell Lung Cancer Death Risk by 40% Updates in Metastatic Non-Small Cell Lung Cancer From ASCO 2025 Small Cell Lung Cancer in 2024: Treatment Advances
- Advanced Non-Small Cell Lung Cancer Updates From ASCO 2024 - Medscape
Practice-changing studies in advanced non-small cell lung cancer presented at ASCO 2024 are reviewed by Dr Ticiana Leal, including the phase 3 LAURA and PALOMA-3 studies and a 5-year update of CROWN
- Why a New Inhalable Lung Cancer Treatment Is So Promising - Medscape
Cheng, who has been developing exosome and stem cell therapies for more than 15 years, and his lab team focused on lung cancer because the disease, often detected in later stages, "has a huge
- Potential Drivers of LCINS - Medscape
During a plenary session at the 2024 World Congress on Lung Cancer, experts addressed the known and suspected causes of LCINS, including fallout from climate change, vaping, cannabis use, and
- Changes in the Treatment Landscape of Early-Stage Non-Small Cell Lung . . .
Dr Narjust Florez explores the transformative shifts in the treatment landscape for early-stage non–small cell lung cancer over the years, particularly emphasizing the significant changes
- Zenocutuzumab Effective Against NRG1 Fusion Cancers - Medscape
The bispecific antibody shows particularly promising results in non–small cell lung cancer (NSCLC) and pancreatic cancer patients, with responses lasting a median of 11 1 months
|
|
|